Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Epidemiological Study of Pregnancy Outcomes and of Events of Interest in Pregnant Women, Neonates and Infants (PEPNI)

NCT03614676 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT03614676
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03614676 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Epidemiological Study of Pregnancy Outcomes and of Events of Interest in Pregnant Women, Neonates and Infants (PEPNI)
Lead sponsor
GlaxoSmithKline
Phase
Not applicable
Overall status
Completed
Start date
May 30, 2019
Completion date
July 27, 2021
Enrollment
4,493 (actual)
Sites
40

Conditions

As the registry lists them; a condition with its own page is linked.

respiratory syncytial virus infections